Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
94,938,677
-
Share change
-
-12,736,758
-
Total reported value
-
$1,598,252,322
-
Put/Call ratio
-
53%
-
Price per share
-
$16.83
-
Number of holders
-
287
-
Value change
-
-$223,745,245
-
Number of buys
-
117
-
Number of sells
-
137
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2021
As of 30 Jun 2021,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
287 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,938,677 shares.
The largest 10 holders included
ARK Investment Management LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, MACQUARIE GROUP LTD, NORTHERN TRUST CORP, Parametric Portfolio Associates LLC, Mondrian Investment Partners LTD, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and WELLS FARGO & COMPANY/MN.
This page lists
287
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.